Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Edasalonexent is an orally bioavailable inhibitor of NF-κB.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 242.00 | |
5 mg | 5 days | $ 297.00 | |
25 mg | 6-8 weeks | $ 987.00 | |
50 mg | 6-8 weeks | $ 1,360.00 | |
100 mg | 6-8 weeks | $ 1,860.00 | |
1 mL * 10 mM (in DMSO) | 5 days | $ 358.00 |
Description | Edasalonexent is an orally bioavailable inhibitor of NF-κB. |
In vitro | Edasalonexent obviously inhibits NF-κB p65-dependent inflammatory responses and downstream proinflammatory genes modulated by p65 in the golden retriever Duchenne muscular dystrophy (DMD) model [2]. |
In vivo | It causes reduced susceptibility of the extensor digitorum longus muscle to eccentric contraction-induced injury, after treatment of mdx mice with Edasalonexent for 20 weeks [1]. |
Synonyms | CAT-1004 |
Molecular Weight | 490.68 |
Formula | C31H42N2O3 |
CAS No. | 1204317-86-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Edasalonexent 1204317-86-1 NF-Κb NF-κB CAT1004 CAT-1004 CAT 1004 inhibitor inhibit